La vacuna anti-covid-19 que está desarrollando la Universidad de Oxford produce una respuesta inmune tanto en ancianos como en jóvenes y las reacciones adversas han sido menores en personas mayores, según comunicó el lunes el fabricante británico de medicamentos AstraZeneca Plc.
ADVERTISEMENT
Hi there i am kavin, its my first time to commenting anywhere, when i read this article i
thought i could also create comment due to this
good post.
I do not even know the way I stopped up here, however I believed this publish was once great.
I do not realize who you might be however definitely you are going to a
well-known blogger when you aren’t already. Cheers!